132 related articles for article (PubMed ID: 1774957)
1. Immunoreactivity of leukemic lymphoblasts of T-cell and B-cell precursor origin with monoclonal anti-GD3 and anti-GM3 antibodies.
Merritt WD; Sztein MB; Taylor B; Reaman GH
Leukemia; 1991 Dec; 5(12):1087-91. PubMed ID: 1774957
[TBL] [Abstract][Full Text] [Related]
2. Anti-GD3 monoclonal antibody analysis of childhood T-cell acute lymphoblastic leukemia: detection of a target antigen for antibody-mediated cytolysis.
Reaman GH; Taylor BJ; Merritt WD
Cancer Res; 1990 Jan; 50(1):202-5. PubMed ID: 2403416
[TBL] [Abstract][Full Text] [Related]
3. Detection of GD3 ganglioside in childhood acute lymphoblastic leukemia with monoclonal antibody to GD3: restriction to immunophenotypically defined T-cell disease.
Merritt WD; Sztein MB; Reaman GH
J Cell Biochem; 1988 May; 37(1):11-9. PubMed ID: 3292545
[TBL] [Abstract][Full Text] [Related]
4. Increased GD3 ganglioside in plasma of children with T-cell acute lymphoblastic leukemia.
Merritt WD; Der-Minassian V; Reaman GH
Leukemia; 1994 May; 8(5):816-22. PubMed ID: 8182939
[TBL] [Abstract][Full Text] [Related]
5. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
Nakakuma H; Horikawa K; Kawaguchi T; Hidaka M; Nagakura S; Hirai S; Kageshita T; Ono T; Kagimoto T; Iwamori M
Jpn J Clin Oncol; 1992 Oct; 22(5):308-12. PubMed ID: 1469793
[TBL] [Abstract][Full Text] [Related]
6. Expression of GD3 ganglioside in childhood T-cell lymphoblastic malignancies.
Merritt WD; Casper JT; Lauer SJ; Reaman GH
Cancer Res; 1987 Mar; 47(6):1724-30. PubMed ID: 3493067
[TBL] [Abstract][Full Text] [Related]
7. GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12.
Helfand SC; Dickerson EB; Munson KL; Padilla ML
Cancer Res; 1999 Jul; 59(13):3119-27. PubMed ID: 10397254
[TBL] [Abstract][Full Text] [Related]
8. Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen.
Nores GA; Dohi T; Taniguchi M; Hakomori S
J Immunol; 1987 Nov; 139(9):3171-6. PubMed ID: 3668254
[TBL] [Abstract][Full Text] [Related]
9. An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo.
Dohi T; Nores G; Hakomori S
Cancer Res; 1988 Oct; 48(20):5680-5. PubMed ID: 3167827
[TBL] [Abstract][Full Text] [Related]
10. R24 anti-GD3 ganglioside antibody can induce costimulation and prevent the induction of alloantigen-specific T cell clonal anergy.
Boussiotis VA; Pardo NA; Collins H; Houghton A; Ritz J; Nadler LM; Soiffer RJ
Eur J Immunol; 1996 Sep; 26(9):2149-54. PubMed ID: 8814260
[TBL] [Abstract][Full Text] [Related]
11. Homophilic binding of mouse monoclonal antibodies against GD3 ganglioside.
Chapman PB; Yuasa H; Houghton AN
J Immunol; 1990 Aug; 145(3):891-8. PubMed ID: 1695649
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of ganglioside and asialoglycosphingolipid antigens in adult T-cell leukemia cells.
Suzuki Y; Hirabayashi Y; Matsumoto N; Kato H; Hidari K; Tsuchiya K; Matsumoto M; Hoshino H; Tozawa H; Miwa M
Jpn J Cancer Res; 1987 Oct; 78(10):1112-20. PubMed ID: 2890614
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
14. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
Furukawa K; Yamaguchi H; Oettgen HF; Old LJ; Lloyd KO
Cancer Res; 1989 Jan; 49(1):191-6. PubMed ID: 2908845
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
[TBL] [Abstract][Full Text] [Related]
16. Increased proliferation, cytotoxicity, and gene expression after stimulation of human peripheral blood T lymphocytes through a surface ganglioside (GD3).
Norihisa Y; McVicar DW; Ghosh P; Houghton AN; Longo DL; Creekmore SP; Blake T; Ortaldo JR; Young HA
J Immunol; 1994 Jan; 152(2):485-95. PubMed ID: 8283032
[TBL] [Abstract][Full Text] [Related]
17. Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity.
Chapman PB; Lonberg M; Houghton AN
Cancer Res; 1990 Mar; 50(5):1503-9. PubMed ID: 2105840
[TBL] [Abstract][Full Text] [Related]
18. The antibody to GD3 ganglioside, R24, is rapidly endocytosed and recycled to the plasma membrane via the endocytic recycling compartment. Inhibitory effect of brefeldin A and monensin.
Iglesias-Bartolomé R; Crespo PM; Gomez GA; Daniotti JL
FEBS J; 2006 Apr; 273(8):1744-58. PubMed ID: 16623710
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
Kusano A; Ohta S; Shitara K; Hanai N
Anticancer Res; 1993; 13(6A):2207-12. PubMed ID: 8297135
[TBL] [Abstract][Full Text] [Related]
20. Recognition of cell surface GD3 by monoclonal antibody anti-6C2 in rheumatoid arthritis synovial fluid: expression on human T cells with transendothelial migratory activity.
Homma T; Hosono O; Iwata S; Ando S; Sasaki K; Nishi T; Kawasaki H; Tanaka H; Morimoto C
Arthritis Rheum; 2001 Feb; 44(2):296-306. PubMed ID: 11229459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
